ABSTRACT
Medium-chain triglycerides, (MCTs), have a long history of use as a fat source in medical nutrition products. Since they first became commercially available in 1955, patients with fat malabsorption syndromes, premature infants, and the critically ill have benefited from this rapidly absorbed, concentrated source of energy. Their nutritional value is attributed to the unique metabolic pathway of MCTs compared with conventional fats and oils. MCTs are also valued for their unique physical attributes by food technologists and formulators.
